A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc.
Nimbus Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
IFOM ETS - The AIRC Institute of Molecular Oncology
Accent Therapeutics
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
GERCOR - Multidisciplinary Oncology Cooperative Group
University of Pittsburgh
Marengo Therapeutics, Inc.
GERCOR - Multidisciplinary Oncology Cooperative Group
Gruppo Oncologico del Nord-Ovest